Indoco Remedies Q1 FY27 Results (NSE: INDOCO)
Signal: Loss reversed
The read
Q1FY27 headline profit is entirely an accounting gain from the slump sale of the ophthalmic division (₹9,734 lakh exceptional). Core business remains deep in the red: consolidated PBT before exceptional is -₹1,962 lakh, though this has improved from -₹3,666 lakh a year ago on cost cutting. Standalone EBITDA margin improved to 10.3% from 3.8% a year ago, but consolidated operating losses continue. The structural turnaround thesis hinges on whether domestic formulation growth (+12.2% YoY) and cost discipline can drive core profitability without reliance on asset sales.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹466.22 Cr | 8.2% | -2.0% |
| EBIT | ₹-19.62 Cr | N/A | |
| Net profit | ₹65.44 Cr | 280.0% | |
| EPS | ₹7.09 | N/A | |
| EBIT margin | -4.2% |
P&L walk
Revenue +8.2% YoY, but core operating profit (before exceptional) improved only marginally from -₹3,666 lakh loss to -₹1,962 lakh loss; reported profit entirely from one-off gain of ₹9,734 lakh on slump sale of ophthalmic division.
Segments
Only one primary segment (Pharmaceuticals) reported; geography shows India revenue +12.2% YoY (₹31,177 lakh vs ₹27,783 lakh) driving consolidated growth, while international revenue flat (₹15,445 lakh vs ₹15,303 lakh). No segment profit split disclosed.
Key positives
- Domestic formulation revenue grew +12.2% YoY to ₹31,177 lakh, showing resilience in core market.
- Standalone EBITDA margin expanded to 10.3% from 3.8% a year ago, reflecting cost reduction across employee, R&D, and other expenses.
- Core operating loss before exceptional narrowed to -₹1,962 lakh (consolidated) from -₹3,666 lakh YoY.
- Exceptional gain of ₹9,734 lakh from ophthalmic division sale provides cash and removes a loss-making unit.
Key concerns
- Consolidated operating business still loss-making before exceptional items; PBT before exceptional -₹1,962 lakh.
- Depreciation rising +16.3% YoY and finance costs +8.3% YoY continue to pressure margins.
- Subsidiary FPP Holding LLC has negative net worth of ₹3,822.60 lakh, flagged by auditors as material uncertainty (going concern impairment risk).
- Improvement in core profitability driven by cost cuts (employee -5.2%, R&D -14.4%, other expenses -6.1%) may not be sustainable if revenue growth requires investment.
Research and educational content only. Not investment advice.